Operating Lease, Right-of-Use Asset in USD of Transcode Therapeutics, Inc. from Q1 2023 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Transcode Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2023 to Q4 2024.
Transcode Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $37.7K, a 92.2% decline year-over-year.

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$37.7K	-$444K	-92.2%	31 Dec 2024	10-Q	14 Nov 2025
Q3 2024	$150K	-$440K	-74.5%	30 Sep 2024	10-Q	14 Nov 2024
Q2 2024	$262K	-$436K	-62.5%	30 Jun 2024	10-Q	14 Aug 2024
Q1 2024	$372K	-$432K	-53.7%	31 Mar 2024	10-Q	15 May 2024
Q4 2023	$482K			31 Dec 2023	10-K	15 Apr 2025
Q3 2023	$590K			30 Sep 2023	10-Q	14 Nov 2023
Q2 2023	$698K			30 Jun 2023	10-Q	14 Aug 2023
Q1 2023	$804K			31 Mar 2023	10-Q	15 May 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.